Welcome to SPACTRAX
SPACTRAX is the most reliable source for the latest on Blank Check companies and SPACs.
Latest SPAC News
Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy
GlobeNewsWire: Distinguished Investor Group Includes Kraken, American Ventures, Exodus (NYSE: EXOD), XtalPi (2228.hk), DL Holdings (1709.hk) GPTX by Jihan Wu and Leading Institutions
This "Boring" Financial Stock Could Crush Tech Returns
The Motley Fool: SoFi Technologies aims to be a one-stop shop for all things financial. The company is growing by leaps and bounds.
Vanderbilt Report: Warrants Signal Something Bigger Than Capital
Accesswire: BRISTOL, TN / ACCESS Newswire / October 27, 2025 / Four point six million dollars tells half the story. VisionWave Holdings (NASDAQ:VWAV) just converted 403,620 warrants into cash at $11.50 per share.
Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – JSPR
GlobeNewsWire: LOS ANGELES, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against Jasper Therapeutics, Inc. (“Jasper” or “the Company”) (NASDAQ: JSPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of JSPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.
ConnectM Launches Keen Labs Subsidiary to Accelerate AI and Energy Transition Technologies
GlobeNewsWire: MARLBOROUGH, Mass, Oct. 27, 2025 (GLOBE NEWSWIRE) -- ConnectM Technology Solutions, Inc. (“ConnectM”) (OTC: CNTM) today announced the launch of its new, wholly owned technology subsidiary, Keen Labs (www.keenlabs.ai). The new business unit will serve as ConnectM's dedicated innovation and tech product development arm, focused on expanding the Company's presence in artificial intelligence, industrial IoT, battery systems, and distributed energy technologies positioned towards enterprise customers.
Nature's Miracle ("NMHI") Opened Office in Tokyo for the Tokenization Opportunities in Japan
PRNewsWire: TOKYO , Oct. 27, 2025 /PRNewswire/ -- On October 27, Nature's Miracle Holding Inc. (NMHI) ("Nature's Miracle" or the "Company") opened an office in the Toranomon Central Business District of Tokyo and the appointment of a local representative director Yoseuke Morimoto. Tokyo is an international finance hub and Japan has a robust regulatory framework for cryptocurrencies, classifying them as legal assets under the Payment Services Act and requiring crypto exchanges to register with the Financial Services Agency (FSA).
Gorilla Technology to Present at the ThinkEquity Conference
Newsfile Corp: London, United Kingdom--(Newsfile Corp. - October 27, 2025) - Gorilla Technology Group Inc. (NASDAQ: GRRR) ("Gorilla" or the "Company"), a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence and IoT technology, today announced that Chief Financial Officer Bruce Bower will present at the ThinkEquity Conference on October 30 in New York. Event details are as follows: Presentation Date: Thursday, October 30, 2025Presentation Time: 12:00 p.m.
Nauticus Robotics Secures $250 Million Equity Facility and Launches Strategic Initiative to Enter Deep-Sea Rare Earth Mineral Exploration Market
PRNewsWire: HOUSTON , Oct. 27, 2025 /PRNewswire/ -- Nauticus Robotics, Inc. (NASDAQ: KITT, "Nauticus"), a leading innovator in autonomous subsea robotics and software solutions, today announced that it has secured a $250 million Equity Line of Credit ("ELOC") facility to accelerate its next phase of growth and innovation. The facility will provide Nauticus with the flexibility to pursue strategic acquisitions that expand its technological capabilities and position the company to enter the rapidly emerging market for deep-sea rare earth and mineral exploration.
Nauticus Robotics Improves Balance Sheet Through Converting $3.7M Debt to Equity
PRNewsWire: HOUSTON , Oct. 27, 2025 /PRNewswire/ -- Nauticus Robotics, Inc. (NASDAQ: KITT), a leading innovator in autonomous subsea robotics and software solutions, today announced that it has entered into an agreement with existing debtholders to convert $3.7M of debt into common equity. The company anticipates that this conversion will allow it to substantially deleverage the balance sheet.
Research Finds Two in Three US Banking Executives Believe Agentic AI Will Change How the Industry Operates
GlobeNewsWire: While large majority (71%) say they must invest in AI agents to remain competitive, over half (54%) also want stronger regulatory guidance While large majority (71%) say they must invest in AI agents to remain competitive, over half (54%) also want stronger regulatory guidance
Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial
GlobeNewsWire: NEW HOPE, Pa., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, today announced the first patient enrollments in the Virtue SAB in the Treatment of Coronary ISR Trial (“Virtue Trial”), the Company's U.S. IDE pivotal trial comparing its highly differentiated Virtue® Sirolimus AngioInfusionTM Balloon (“Virtue SAB”) to the AGENT paclitaxel-coated balloon, currently the only drug-coated balloon (“DCB”) FDA-approved for a coronary indication. The initial cases were successfully completed by the teams at The Christ Hospital Heart & Vascular Institute in Cincinnati, OH, and St. Francis Hospital & Heart Center in Roslyn, NY, marking the initiation of the Virtue Trial. Dean J. Kereiakes, M.D., FACC, MSCAI, Chairman of The Christ Hospital Heart & Vascular Institute and Medical Director of The Christ Hospital Research Institute and Allen Jeremias M.D., Director of Interventional Cardiology Research and Associate Director, Cardiac Catheterization Laboratory, St. Francis Hospital & Heart Center are co-principial investigators of the Virtue Trial. Designed to support regulatory approval of Virtue SAB, the Virtue Trial is expected to enroll 740 patients at up to 75 centers in the United States with enrollment completion currently planned for mid-2027.
These stocks are falling back to Earth as Trump and China play nice
Market Watch: Stocks of rare-earth companies take a hit as U.S.-China trade tensions ease.
Advent Technologies Commissions Arxicon as Master Planner for RHyno Project
GlobeNewsWire: LIVERMORE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN), through its wholly owned subsidiary Advent Technologies S.A., is pleased to announce its official collaboration with Arxicon, a leading Greek engineering and project management firm, for the development of its master plan for the RHyno Project.
Notice to Shareholders Regarding Settlements
Business Wire: WEST SACRAMENTO, Calif.--(BUSINESS WIRE)--Origin Materials, Inc. (“Origin”) (Nasdaq: ORGN, ORGNW), a technology company with a mission to enable the world's transition to sustainable materials, has entered into binding agreements to settle the shareholder class action lawsuit and the related derivative lawsuit pending in the United States District Court for the Eastern District of California (the “Court”). The proposed settlements resolve all claims asserted against Origin and the other named d.
Halper Sadeh LLC Encourages Microvast Holdings, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Business Wire: NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Microvast Holdings, Inc. (NASDAQ: MVST) breached their fiduciary duties to shareholders. If you currently own Microvast stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about.
1 Incredible Reason to Buy MP Materials' Stock in November
The Motley Fool: China's control over rare-earth elements is creating a major supply risk for the U.S. MP Materials recently secured a major, complex deal with the U.S. Department of Defense. The stock looks expensive today, but government backing and strong magnet demand could justify its valuation.
Butterfly Network Strengthens Global Information Security Posture with ISO 27001, SOC-2 Type 2, C5 Germany, and NHS DSPT Accreditations
Business Wire: BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced it has achieved certification for ISO 27001, the world's leading standard for information security management systems, published by the International Organization for Standardization (ISO) in partnership with the International Electrotechnical Commission (IEC). This globally recognized a.
Halper Sadeh LLC Encourages The Beauty Health Company Shareholders to Contact the Firm to Discuss Their Rights
Business Wire: NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of The Beauty Health Company (NASDAQ: SKIN) breached their fiduciary duties to shareholders. If you currently own Beauty Health stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more a.
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MLTX
GlobeNewsWire: LOS ANGELES, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MLTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.
Halper Sadeh LLC Encourages Lucid Group, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Business Wire: NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Lucid Group, Inc. (NASDAQ: LCID) breached their fiduciary duties to shareholders. If you currently own Lucid stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about your legal.



















